Viridian Therapeutics, Inc. (VRDN) Misses Q4 EPS by 37c

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q4 EPS of ($1.35), $0.37 worse than the analyst estimate of ($0.98).

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Unity Bancorp CEO to retire in 2027, president to take over
• Visa deposits $405M into U.S. litigation escrow, adjusting stock rates